These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33562072)

  • 1. s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation.
    Sharma A; Sheyi R; de la Torre BG; El-Faham A; Albericio F
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting azido-dichloro-triazine as a linker for regioselective incorporation of peptides through their N, O, S functional groups.
    Sharma A; Kumar A; El-Faham A; de la Torre BG; Albericio F
    Bioorg Chem; 2020 Nov; 104():104334. PubMed ID: 33142409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Privileged s-triazines: structure and pharmacological applications.
    Shah DR; Modh RP; Chikhalia KH
    Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided discovery of 1,3,5-triazine-pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate.
    Singh B; Bhat HR; Kumawat MK; Singh UP
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3321-5. PubMed ID: 24961639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
    Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
    Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
    Verma T; Sinha M; Bansal N
    Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3,5-Triazine-based analogues of purine: from isosteres to privileged scaffolds in medicinal chemistry.
    Lim FP; Dolzhenko AV
    Eur J Med Chem; 2014 Oct; 85():371-90. PubMed ID: 25105925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine-Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5-Substituted 1,2,3-Triazines.
    Zuo Q; Li Y; Lai X; Bao G; Chen L; He Z; Song X; E R; Wang P; Shi Y; Luo H; Sun W; Wang R
    Adv Sci (Weinh); 2024 Jun; 11(21):e2308491. PubMed ID: 38466927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.
    Khatir ZZ; Irannejad H
    Mini Rev Med Chem; 2021; 21(19):2874-2928. PubMed ID: 33719962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor Activity of s-Triazine Derivatives: A Systematic Review.
    Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y
    Molecules; 2023 May; 28(11):. PubMed ID: 37298753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives.
    Sarhan MO; Motaleb MA; Ibrahim IT; Anwar MM; Zaghary WA
    Mini Rev Med Chem; 2018; 18(15):1302-1320. PubMed ID: 28971773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Triorthogonal Chemoselectivity. Effect of Azide Substitution on the Triazine Core.
    Sharma A; Sheyi R; Kumar A; El-Faham A; de la Torre BG; Albericio F
    Org Lett; 2019 Oct; 21(19):7888-7892. PubMed ID: 31532213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
    H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial catabolism of s-triazine herbicides: biochemistry, evolution and application.
    Esquirol L; Peat TS; Sugrue E; Balotra S; Rottet S; Warden AC; Wilding M; Hartley CJ; Jackson CJ; Newman J; Scott C
    Adv Microb Physiol; 2020; 76():129-186. PubMed ID: 32408946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.
    Alizadeh SR; Ebrahimzadeh MA
    Eur J Med Chem; 2021 Nov; 223():113537. PubMed ID: 34147747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
    Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
    Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.